BrexitDB.com
Home
Themes
Types
DB
About
item:
#19963
UK approved fewer new drugs than EU and US in year after Brexit transition
14/07/2022
Fears extra expense and paperwork caused by Brexit will make Britain unattractive to global drugmakers.
https://www.theguardian.com/
news
Association of the British Pharmaceutical Industry
BioIndustry Association
bureaucracy
David Watson
disruption
EMA
James Barlow
medicine
MHRA
NICE
research
Steve Bates
